Viewing Study NCT06596551



Ignite Creation Date: 2024-10-26 @ 3:40 PM
Last Modification Date: 2024-10-26 @ 3:40 PM
Study NCT ID: NCT06596551
Status: RECRUITING
Last Update Posted: None
First Post: 2024-09-11

Brief Title: Aspirational Rehabilitation Coaching for Holistic Health ARCH A Pilot Pre-Post Experimental Study
Sponsor: None
Organization: None

Study Overview

Official Title: Aspirational Rehabilitation Coaching for Holistic Health ARCH A Pilot Pre-Post Evaluation of Psychosocial Recovery in First-Time Stroke Survivors and Family Caregivers
Status: RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The ARCH programme is a novel strength-based dyadic multicomponent psychosocial intervention that blends together psychoeducation psychosocial support and self-compassion practices to aid first-time stroke survivors and their family caregivers with their psycho-socio-emotional and spiritual challenges following discharge from in-patient care A pre-post experimental design with a feasibility and acceptability assessment is adopted to evaluate and refine the ARCH intervention in promoting wellbeing self-compassion independence quality of life hope resilience self-efficacy and dyadic mutuality
Detailed Description: Objective The current study utilizes the empirical foundations of psychosocial recovery in first-time stroke dyads to pilot test the Aspirational Rehabilitation Coaching for holistic Health ARCH programme The core objectives of this study is to 1 critically assess the pre-post effects in participants psycho-socio-emotional and spiritual wellbeing and 2 qualitatively evaluate the feasibility and acceptability of the intervention in addressing post-stroke psychosocial challenges

Methods For this pilot study a total of 30 survivor-caregiver dyads N60 30 survivors 30 caregivers will be recruited directly through referrals from the collaborating hospital The proposed sample size reflects the approximate or working number of qualitative interviews at which one could expect to be reach theoretical saturation Morse 2000 Participants above the ages of 21 years recovering from their first stroke at mild to moderate degree of severity discharged from inpatient care at no later than 3 months clinically assessed to have cognitive capacities to engage in and complete the research study with language capabilities in English or Mandarin and one identified primary family caregiver over the age of 21 will be recruited for this study Consenting family dyads will undergo a 4-week dyadic intervention that integrates psychoeducation psychosocial support and self-compassion practices The rationale for the intervention components was based on an in-depth analysis of the psychosocial needs and challenges of stroke survivors and family caregivers reported in the international literature and the lived experiences of post-stroke loss coping strategies and recovery needs of Singaporean first-time stroke survivors and family caregivers Quantitative measurements will be taken at baseline time point 1 T1 immediately after the intervention T2 3 months T3 and 6 months T4 post-intervention The qualitative assessment of feasibility and acceptability will be conducted at post intervention T2

Significance The absence of tailored family-centered support in current stroke rehabilitation practices suggest that more and more individuals are left to their own devices in navigating this psychologically socially and emotionally devastating health event Dyads participating in this study will experience for the first time ever a rehabilitative programme that is solely focused in providing them the comfort and support in managing their unique psycho-socio-emotional and spiritual challenges post-stroke Results from this study hope to inform the large stroke community and eventually find advocate for the ARCH intervention to become a part of standard clinical care

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None